AIRS Medical's SwiftMR® Receives FDA Approval for Integration with OEM Deep Learning Solutions

AIRS Medical's SwiftMR® Achieves FDA Authorization

AIRS Medical has exciting news for healthcare providers and imaging centers as it announces that its innovative product, SwiftMR®, has received FDA 510(k) approval. What does this mean for the field of medical imaging?

SwiftMR® is a supplier-independent MRI image enhancement solution designed to work seamlessly with original equipment manufacturers (OEM) deep learning reconstruction solutions. This development opens new avenues for optimizing patient care and operational efficiency.

Improved MRI Scan Efficiency

SwiftMR® functions in conjunction with existing DL OEM solutions in two significant ways. Firstly, when a facility already has a DL OEM installed, SwiftMR® can work together with it to provide a further reduction in scan times. For instance, in a diagnostic imaging center using a GE 3T scanner with AIR Recon DL, SwiftMR® has successfully decreased routine brain scan times from 15 to just 9 minutes! This remarkable speed-up in processing can enhance patient throughput drastically.

Secondly, if a DL OEM solution is not available for certain sequences, SwiftMR® can fill that gap, allowing for artificial intelligence-driven image improvements that reduce examination time across all pulse sequences and body parts. Since its introduction, SwiftMR® has been clinically utilized since 2023, and its comprehensive coverage has been validated by the FDA, establishing its role as a reliable asset in diagnostic imaging.

Impacts on Appointment Scheduling

As emphasized by AIRS Medical's Chief Strategy Officer, Jina Park, significant reductions in scan durations can have transformative impacts on appointment scheduling. The difference between a 15-minute and a 10-minute scan may seem minor, but it could enable centers to transition from 30-minute appointments to 20-minute ones. This efficiency can lead to better resource management and an enhanced patient experience.

Moreover, Woojin Jung, AIRS Medical's product lead, highlighted that over the past year, SwiftMR® has been specifically trained on images processed through DL OEM systems, tested across various vendors, and field strengths. The recent FDA clearance solidifies customers' confidence to integrate SwiftMR® with their current DL OEM solutions, ensuring quality standards are met.

Availability and Implementation

SwiftMR®, now paired with OEM deep learning solutions, is readily available for imaging centers and hospitals looking to accelerate their scanning processes and improve appointment scheduling. Healthcare facilities eager to upgrade their imaging capabilities can visit airsmed.com for more information and request a live demonstration.

Conclusion

SwiftMR® by AIRS Medical not only optimizes the MRI imaging process but is also an integral part of the ongoing trend toward digitization and automation in healthcare. It brings faster and more reliable diagnostic procedures to imaging centers, enhancing both patient outcomes and operational workflows. The collaboration of AI with traditional imaging technology signifies a promising future in medical diagnostics. For further information on SwiftMR® and its broader applications, check out the latest offerings at airsmed.com.

About AIRS Medical

AIRS Medical is an international company specializing in AI-driven medical imaging solutions. Their innovative products, SwiftMR® and SwiftSight®, are implemented widely across leading healthcare systems and diagnostic imaging networks worldwide. For further exploration of their offerings, visit airsmed.com.